Literature DB >> 21486940

Prognostic value of the ABCD² clinical prediction rule: a systematic review and meta-analysis.

Rose Galvin1, Colm Geraghty, Nicola Motterlini, Borislav D Dimitrov, Tom Fahey.   

Abstract

OBJECTIVE: The purpose of this systematic review with meta-analysis is to determine the predictive value of the ABCD ²at 7 and 90 days across three strata of risk. Background. The risk of stroke after transient ischaemic attack (TIA) is significant. The ABCD ²clinical prediction rule is designed to predict early risk of stroke after TIA. A number of independent validation studies have been conducted since the rule was derived.
METHODS: A systematic literature search was conducted to identify studies that validated the ABCD². The derived rule was used as a predictive model and applied to subsequent validation studies. Comparisons were made between observed and predicted number of strokes stratified by risk group: low (0-3 points), moderate (4-5 points) and high (6-7 points). Pooled results are presented as risk ratios (RRs) with 95% confidence intervals (CIs), in terms of over-prediction (RR > 1) or under-prediction (RR < 1) of stroke at 7 and 90 days.
RESULTS: We include 16 validation studies. Fourteen studies report 7-day stroke risk (n = 6282, 388 strokes). The ABCD² rule correctly predicts occurrence of stroke at 7 days across all three risk strata: low [RR 0.86, 95% CI (0.47-1.58), I² = 16%], moderate [RR 0.99, 95% CI (0.67-1.47), I² = 68%] and high [RR 0.84, 95% CI (0.6-1.19), I² = 46%]. Eleven studies report 90-day stroke risk (n = 6304). There is a non-significant trend towards over-prediction of stroke in all risk categories at 90 days. There are 426 strokes observed in contrast to a predicted 626 strokes. As the trichotomized ABCD² score increases, the risk of stroke increases (P < 0.01). There is no evidence of publication bias in these studies (P > 0.05).
CONCLUSION: The ABCD² is a useful CPR, particularly in relation to 7-day risk of stroke.

Entities:  

Mesh:

Year:  2011        PMID: 21486940     DOI: 10.1093/fampra/cmr008

Source DB:  PubMed          Journal:  Fam Pract        ISSN: 0263-2136            Impact factor:   2.267


  7 in total

1.  A simplified approach to the pooled analysis of calibration of clinical prediction rules for systematic reviews of validation studies.

Authors:  Borislav D Dimitrov; Nicola Motterlini; Tom Fahey
Journal:  Clin Epidemiol       Date:  2015-04-16       Impact factor: 4.790

2.  Validation of the RRE-90 Scale to Predict Stroke Risk after Transient Symptoms with Infarction: A Prospective Cohort Study.

Authors:  Bo Song; Lulu Pei; Hui Fang; Lu Zhao; Yuan Gao; Yuanyuan Wang; Song Tan; Yuming Xu
Journal:  PLoS One       Date:  2015-09-22       Impact factor: 3.240

3.  The Value of ABCD2F Scoring System (ABCD2 Combined with Atrial Fibrillation) to Predict 90-Day Recurrent Brain Stroke.

Authors:  Mostafa Almasi; Nader Hodjati Firoozabadi; Faeze Ghasemi; Mojtaba Chardoli
Journal:  Neurol Res Int       Date:  2016-08-23

4.  Assessment of cerebral infarction after transient cerebral ischemic attack by ABCD2 score combined with the position of intracranial vascular stenosis.

Authors:  Hong-Yan Xi; Zhi-Hua Si; Jia-Cheng Li; Jian-Guo Zhu; Hai-Yan Yan
Journal:  Medicine (Baltimore)       Date:  2019-04       Impact factor: 1.817

Review 5.  Transient ischemic attacks: predictability of future ischemic stroke or transient ischemic attack events.

Authors:  Harsh V Gupta; Ann M Farrell; Manoj K Mittal
Journal:  Ther Clin Risk Manag       Date:  2014-01-08       Impact factor: 2.423

6.  Long-term risk of stroke after transient ischaemic attack: a hospital-based validation of the ABCD² rule.

Authors:  Rose Galvin; Penka A Atanassova; Nicola Motterlini; Tom Fahey; Borislav D Dimitrov
Journal:  BMC Res Notes       Date:  2014-05-04

Review 7.  Blockchain and artificial intelligence technology in e-Health.

Authors:  Priti Tagde; Sandeep Tagde; Tanima Bhattacharya; Pooja Tagde; Hitesh Chopra; Rokeya Akter; Deepak Kaushik; Md Habibur Rahman
Journal:  Environ Sci Pollut Res Int       Date:  2021-09-02       Impact factor: 4.223

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.